George Diaz

Vice President, Urea Cycle Disorders & Therapeutic Area Lead iECURE

George Diaz, M.D., Ph.D., currently serves as VP, Therapeutic Area Lead for Urea Cycle Disorders (UCDs) at iECURE. Dr. Diaz joins the company with more than 25 years of experience in genetics and pediatrics, particularly in metabolic diseases and monogenic disorders. Most recently, he served as chief of the division of Medical Genetics and professor in the Departments of Genetics & Genomic Sciences and Pediatrics at Icahn School of Medicine at Mount Sinai in New York. Over his remarkable career at Mount Sinai, Dr. Diaz has collaborated extensively with industry partners to bring novel therapeutics to patients with UCDs and other rare genetic disorders. In addition to his roles at Mount Sinai, he has served as director of the Program for Inherited Metabolic Diseases, a nationally recognized specialty center for the evaluation and care of patients with inborn errors of metabolism.

Seminars

Thursday 30th July 2026
Examining Clinical Trial Progress & Adaptive Strategies for Safer In Vivo Gene Editing
3:30 pm
  • Sharing early clinical data from ongoing patients dosing, accelerating confidence in therapeutic potential
  • Implementing adaptive cohort designs and monitoring frameworks, improving trial flexibility and patient safety
  • Aligning eligibility and dosing strategies with evolving biomarker insights, ensuring efficient global progression 
George Diaz of iECURE - 5th In Vivo Cell Engineering & Gene Editing Summit
View all Speakers
View Event Brochure